|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Contraceptives and HIV transmission. Marx replies [letter] |
| NATURE MEDICINE. 1997 Feb;3(2):124. |
| We agree with the above opinions regarding the information gleaned from the literature and from their studies on |
| Depo-Provera. David Satcher (Director of the Centers for Disease Control and Prevention) stresses that any woman |
| who wishes to control fertility and has found a suitable contraceptive method should continue using it, but dual |
| methods should be used for persons who are at risk of HIV infection. Only abstinence and male latex condoms have |
| been shown to effectively prevent sexual transmission of HIV. In fact, the US Food and Drug Administration already |
| requires that non-barrier contraceptives must include labeling stating that they do not provide protection against HIV |
| infection. Duerr et al. point out that the effects of progestins on HIV transmission will be difficult to determine. This |
| is also true and is the reason we used the monkey model. This model provides the opportunity to test hypotheses in |
| a controlled manner that would be impossible in human subjects. Duerr et al. also indicate that the risk of SIV |
| infection throughout the menstrual cycle may be less than the 7.7-fold we reported. This is a possible interpretation |
| of some of our data, but was not in the design of the study and sufficient animals were not used to study this in |
| particular. Our study only tested the hypothesis that progesterone enhanced vaginal transmission of SIV, and that |
| hypothesis was proven. The question posed by Duerr et al. is being addressed in our new study. (full text modified) |
| (PubHealth.info Document ID: CONT2T 515-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Contraceptives and HIV transmission. Marx replies [letter]", |
| is(are) Marx PA. The source of this article is "NATURE MEDICINE. 1997 Feb;3(2):124.". This article was published |
| in 1997 in English language(s). (PubHealth.info® Document ID: CONT2T 515-06. All rights reserved with |
| PubHealth.info) PIN: 5515 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |